2-tert-Butyloxycarbonylaminomethyl-5-(4-chlorophenyl)-[1,3,4]oxadiazole, 95.0%, 1g

(Hydroxymethyl)diphenylphosphine oxide, 98+%, 250mg

Colonne capillaire GC ROTI®Cap-5, 25 m, 0,25 mm, 0,10 µm, 1 pièce(s)

5-(Methoxymethyl)-1-methyl-1H-pyrazole-3-carboxylic acid, 5g

2-Chloro-4-ethylquinoline-3-carbonitrile, 95.0%, 100mg

2,3,6,7,8,9-HEXAHYDRO-1H-CYCLOPENTA[A]NAPHTHALEN-1-ONE, 95.0%, 5g

2-(Trifluoromethyl)-1,4-phenylenediamine>98.0%(GC)(T)1g

Acétophénone, min 98%, pour synthèse, 1L, conditionnement verre

1-CYCLOBUTYL-1H-PYRAZOLE-3-CARBOXYLIC ACID, 95%, 5g

4-((Ethylamino)methyl)aniline, 98%, 1g

(S)-6,6'-Bis(bis(3,5-bis(trimethylsilyl)phenyl)phosphino)-2,2',3,3'-tetrahydro-5,5'-bibenzo[b][1,4]dioxine, 98%, 1g

(S)-3-Amino-1-benzyl-piperidine, 97.0%, 250mg

TERT-BUTYL (2R)-2-METHYL-4-OXOPYRROLIDINE-1-CARBOXYLATE, 95%, 25g